DNA:NYSE, Ginkgo Bioworks Holdings, Inc.

DNA stock overview

Ginkgo Bioworks Holdings, Inc. (DNA:NYSE) closed at $9.99 on October 23, 2026, up 2.88% on the day. The stock trades 45.2% below its 52-week high of $18.22 and 86.0% above its 52-week low of $5.37. Over the past year, it lost 26.4%. Ginkgo Bioworks Holdings, Inc. is part of the Technology sector.

Key figures

Price

$9.99

Day change

+2.88%

Volume

1,149,795

Average volume

2,060,767

Market cap

672M+

52-week range

$5.37 – $18.22

50-day average

$9.02

200-day average

$8.53

Price action over the past year

In 252 trading sessions since October 23, 2025, DNA closed higher on 118 days (47%). Its best day was February 6, 2026 (+21.39%) and its worst was February 27, 2026 (-30.48%). The stock moved 10% or more in a single session 21 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

• Oct 20, 2026: News catalyst: Investor Update (News Catalysts scanner)
• Oct 6, 2026: Spiked to $18.22 on 13M+ shares (Spikes scanner)

DNA news

• Oct 24, 2026: What Ginkgo Bioworks Bears Saw Before The Fall
• Oct 20, 2026: Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
• Oct 14, 2026: Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand
• Oct 14, 2026: Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
• Oct 8, 2026: Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
• Oct 8, 2026: Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
• Oct 7, 2026: Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know
• Oct 5, 2026: This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Similar stocks

• VTEX:NYSE
• DQ:NYSE
• BTGO:NYSE
• YEXT:NYSE
• JBI:NYSE
• AVEX:NYSE
• WEAV:NYSE
• CARS:NYSE

Find more stocks like DNA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.